2022 First Half Portfolio🚨
.
Definitely not the model portfolio that anyone wants to follow
.
Painful experience early this year
.
There’s still however no clear sign about how the market is going for the rest of 2022
.
There’s definitely still more rooms to fall if the macroeconomic continues to worsen or remain stagnant
.
Nonetheless, in tough times like this, it is about time to store bullets and start loading on some convictions stocks
.
New addition: #AMZN #SPYG #CITI
.
Upfront, I’m preparing to increase my #AAPL exposure, #SPYG & keep a lookout for semiconductor companies.
.
Both #TSLA & #PLTR have taken heavy blows and punishments.
.
I will not be adding more PLTR as I’m already sitting with a very substantial amount of the stock. May consider to average down my Tesla positions.
.
I know, this is a portfolio with too much noise. Will not be trimming down the random positions at tough time like this, but just sit back and endure the pain, until green days are back.
.
This is not an investment advice post
.
Consistency is key 🔑
Stay motivated 🔥
Be inspired 💡
Invest safe 💵
.
#invest #portfolio #review #stocks
.
Definitely not the model portfolio that anyone wants to follow
.
Painful experience early this year
.
There’s still however no clear sign about how the market is going for the rest of 2022
.
There’s definitely still more rooms to fall if the macroeconomic continues to worsen or remain stagnant
.
Nonetheless, in tough times like this, it is about time to store bullets and start loading on some convictions stocks
.
New addition: #AMZN #SPYG #CITI
.
Upfront, I’m preparing to increase my #AAPL exposure, #SPYG & keep a lookout for semiconductor companies.
.
Both #TSLA & #PLTR have taken heavy blows and punishments.
.
I will not be adding more PLTR as I’m already sitting with a very substantial amount of the stock. May consider to average down my Tesla positions.
.
I know, this is a portfolio with too much noise. Will not be trimming down the random positions at tough time like this, but just sit back and endure the pain, until green days are back.
.
This is not an investment advice post
.
Consistency is key 🔑
Stay motivated 🔥
Be inspired 💡
Invest safe 💵
.
#invest #portfolio #review #stocks
Novo Nordisk stock is down over 50% from its highs — is this a rare buying opportunity or a value trap? In this no-fluff breakdown, I take you through why the stock dropped, the Hims & Hers controversy, and disappointing CagriSema trial data that may have shifted investor sentiment.
As one of my largest positions in a 6-figure portfolio, this isn’t theory — this is my personal Investment Diary.
We’ll also go deep into the company’s financials, forward valuation, dividend strength, free cash flow, and long-term competitive positioning versus Eli Lilly. I’ll also share my fair value estimates and DCF analysis to help you decide: Buy, Hold, or Sell?
Full video:
https://youtu.be/RHopPp0WGXE?si=kB0V9_GVErX5LFvz
As one of my largest positions in a 6-figure portfolio, this isn’t theory — this is my personal Investment Diary.
We’ll also go deep into the company’s financials, forward valuation, dividend strength, free cash flow, and long-term competitive positioning versus Eli Lilly. I’ll also share my fair value estimates and DCF analysis to help you decide: Buy, Hold, or Sell?
Full video:
https://youtu.be/RHopPp0WGXE?si=kB0V9_GVErX5LFvz
YouTube
Novo Nordisk Just Crashed! Buy the Dip or Stay Away? — Here’s What I’m Doing #stocks
Novo Nordisk stock is down over 50% from its highs — is this a rare buying opportunity or a value trap? In this no-fluff breakdown, I take you through why the stock dropped, the Hims & Hers controversy, and disappointing CagriSema trial data that may have…